Signaling Pathways - sodium chloride cotransporter - PAR - MDM2 - Insulin and Insulin-like Receptors
清除全部
- B1950 Hydrochlorothiazide中文名: 氢氯噻嗪Target: sodium chloride cotransporterSummary: 噻嗪类利尿药
- A8675 TRAP-6中文名: 凝血酶受体激活肽6Target: PARSummary: PAR1激动剂
- A8669 AC 55541Target: PARSummary: PAR2激动剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂
- A3762 RG71125 CitationTarget: MDM2Summary: MDM2抑制剂
- A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂
- A4302 Rosiglitazone maleate中文名: 马来酸罗格列酮Target: Insulin and Insulin-like ReceptorsSummary: PPARγ激动剂,有效的胰岛素敏化剂
- A4228 Nutlin-3Target: MDM2Summary: MDM2 拮抗剂